No-moat, positive-moat-trend rated Autoliv ALV reported first-quarter earnings per share before special items of $1.32, $0.09 ahead of the Street consensus of $1.23. Even so, owing to lackluster European new-car demand and Autoliv’s European customers’ inventory corrections, the $1.32 first-quarter EPS were down $0.24 from $1.56 a year ago. However, management favorably tweaked its full-year…
Roche’s (RHHBY) $8.3 billion deal, announced over the weekend, to take over biotech firm InterMune (ITMN) triggered significant stock price appreciation in many mid-cap firms in the space on Aug 25. Switzerland-based Roche is looking to strengthen its respiratory portfolio through the impending InterMune buy. The offer price of $74.00 per share represents a premium…
Here in this article, we take a good look at three upcoming Biotech Stocks, namely, InterMune, Advaxis, Inc & Amgen, Inc. InterMune Inc (NASDAQ ITMN) listed its shares as a big mover previous session, as its shares jumped over 35% after Roche AG’s declaration it would buy the respiratory-drug maker for $8.3B, in spite of…
SBA Communications SBAC notched another strong firstquarter result, highlighted by better-than-expected earnings and another guidance upgrade. First-quarter revenues grew by 62% year over year to $313 million–roughly 4% above consensus. The growth was driven by a 64.1% increase in the firm’s tower base, which now stands at 17,539. Once again, however, SBA’s growth was in…
Chinese Internet firm Sohu SOHU posted first-quarter revenue and earnings that slightly exceeded the firm’s guidance and our internal estimate, thanks to solid top-line growth across brand advertising, search, and gaming. Revenue grew by 36% year over year to $308 million (versus $299 million at the high end of guidance), while non-GAAP net income came…
Fed Chair Janet Yellen testified before the US Senate Committee on Banking, Housing, and Urban Affairs. She presented the Fed’s semiannual Monetary Policy Report (MPR) to the Congress. In her prepared remarks, she stated that while valuation seems “stretched” in some areas of the bond market, equities “remain generally in line with historical norms.” Yet…
